Skip to main content

Advertisement

SpringerLink
Log in

Effect of a single intrastriatal rotenone injection on oxidative stress and neurodegeneration in the rat brain

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

We investigated the effect of a single injection of rotenone into the striatum on the development of oxidative stress, nigrostriatal cell injury and motor alterations in rats. Rotenone (1, 3, 5 and 9 mM; 5 μL/rat) or the vehicle (dimethyl sulfoxide) was injected into the right striatum. Control rats received the vehicle only. Rats were allowed to recover from the operation and were tested for behavioural changes on 7th and 30th days after rotenone injection. Biochemical markers of oxidative stress including malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide, paraoxonase 1 (PON1) activity and Q10 enzyme as well as monoamine neurotransmitters in the brain were determined after 30 days of rotenone treatment. Histopathology and tyrosine hydroxylase immunohistochemistry were also performed. Results: Intrastriatal injection of rotenone at 9 mM caused immediate death of rats. No mortality was observed with the lower concentrations of the pesticide. Rotenone at 1–5 mM resulted in increased brain oxidative stress in a dose-dependent manner. MDA increased by 23.5–64.9 %, while GSH decreased by 20.4–24.1 % in the contralateral cerebral hemisphere. Nitric oxide increased by 20.2–41.7 % in ipsilateral cortex. PON1 activity decreased by 12.5–38.2 % in ipsilateral cerebral cortex and by 31.2–65.3 % in ipsilateral striatum, respectively, but coenzyme Q10 increased in the ipsilateral cortex by 21–26.3 %. There was decreased dopamine and serotonin in the ipsilateral striatum after rotenone injection. Tyrosine hydroxylase immunoreactivity was markedly decreased in ipsilateral substantia nigra in the rotenone-treated in contrast to the vehicle-treated rats. Rotenone increased the number of degenerated cells in substantia nigra in a dose-dependent manner. It also caused depletion of pigment granules from cells. Degenerative changes were also observed in the contralateral hippocampus and cortex especially after the highest dose of rotenone. The number of spontaneous rears made during 30 min in the cylinder was decreased in both limbs; the decrease being more evident in the ipsilateral side. Thus, a single intrastriatal injection of rotenone (a) caused a significant nigrostriatal degeneration and loss of dopamine and serotonin from the striatum; (b) elicited cell degeneration in the hippocampus and cortex; (c) induced oxidative stress and neuronal injury (this latter effect of rotenone was not region specific); and (d) the motor deficits (decreased rearing activity) occurred in both limbs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317–324

    Article  PubMed  CAS  Google Scholar 

  • Berardelli A, Rothwell JC, Thompson PD, Hallett M (2001) Pathophysiology of bradykinesia in Parkinson’s disease. Brain 124:2131–2146

    Article  PubMed  CAS  Google Scholar 

  • Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306

    Article  PubMed  CAS  Google Scholar 

  • Clifford W, Shults T (2005) Therapeutic role of coenzyme Q10 in Parkinson’s disease. Pharmacol Ther 107:120–130

    Article  Google Scholar 

  • Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20:591–598

    Article  PubMed  CAS  Google Scholar 

  • Delaville C, Deurwaerdère PD, Benazzouz A (2011) Noradrenaline and Parkinson’s disease. Front Syst Neurosci 5:31

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Double KL, Gerlach M, Youdim MB, Riederer P (2000) Impaired iron homeostasis in Parkinson’s disease. J Neural Transm Suppl 60:37–58

    PubMed  Google Scholar 

  • Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–671

    Article  PubMed  CAS  Google Scholar 

  • Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem 82:70–77

    Article  PubMed  CAS  Google Scholar 

  • Feng Y, Liang ZH, Wang T, Qiao X, Liu HJ, Sun SG (2006) alpha-Synuclein redistributed and aggregated in rotenone-induced Parkinson’s disease rats. Neurosci Bull 22:288–293

    PubMed  CAS  Google Scholar 

  • Ferrante RJ, Schulz JB, Kowall NW, Beal MF (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res 753:157–162

    Article  PubMed  CAS  Google Scholar 

  • Furlong CE (2008) Paraoxonases: an historical perspective. In: Mackness B, Mackness M, Aviram M, Paragh G (eds) The paraoxonases: their role in disease development and xenobiotic metabolism. Springer, Dordrecht, pp 3–31

    Google Scholar 

  • Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623

    Article  PubMed  CAS  Google Scholar 

  • Halliwell N (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685–716

    Article  PubMed  CAS  Google Scholar 

  • Halliwell B, Cross CE (1994) Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102(Suppl 10):5–12

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Higashino K, Takahashi Y, Yamamura Y (1972) Release of phenyl acetate esterase from liver microsomes by carbon tetrachloride. Clin Chim Acta 41:313–320

    Article  PubMed  CAS  Google Scholar 

  • Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397

    Article  PubMed  CAS  Google Scholar 

  • Horvath TL, Diano S, Leranth C, Garcia-Segura LM, Cowley MA, Shanabrough M, Elsworth JD, Sotonyi P, Roth RH, Dietrich EH, Matthews RT, Barnstable CJ, Redmond DE Jr (2003) Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson’s disease. Endocrinology 144:2757–2760

    Article  PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Islam MB (2006) Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world. Annu Rev Entomol 51:45–66

    Article  Google Scholar 

  • Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H (2009) Paraoxonase 1 activity in different types of multiple sclerosis. Mult Scler 15:399–402

    Article  PubMed  CAS  Google Scholar 

  • Janáky R, Cruz–Aguado R, Oja SS, Shaw CA (2007) Glutathione in the nervous system: roles in neural function and health and implications for neurological disease. In: Lajtha A, Oja SS, Schousboe A, Saransaari P (eds) Handbook of neurochemistry and molecular neurobiology. Springer-Verlag, Berlin, pp 349–385

    Google Scholar 

  • Jellinger KA (2002) Recent developments in the pathology of Parkinson’s disease. J Neural Transm Suppl 62:347–376

    Article  PubMed  CAS  Google Scholar 

  • Kalia LV, Brotchie JM, Fox SH (2013) Novel nondopaminergic targets for motor features of Parkinson’s disease: review of recent trials. Mov Disord 28:131–144

    Article  PubMed  CAS  Google Scholar 

  • La Du BN (1992) Human serum paraoxonase: arylesterase. In: Kalow W (ed) Pharmacogenetics of drug metabolism. Pergamon, Elmford, pp 51–91

    Google Scholar 

  • Lapointe N, St-Hilaire M, Martinoli MG, Blanchet J, Gould P, Rouillard C, Cicchetti F (2004) Rotenone induces non-specific central nervous system and systemic toxicity. FASEB J 18:717–719

    PubMed  CAS  Google Scholar 

  • Lotharius J, Brundin P (2002) Pathogenesis of Parkinson’s disease: dopamine, vesicles and α-synuclein. Nat Rev Neurosci 3:932–942

    Article  PubMed  CAS  Google Scholar 

  • Mischley LK, Allen J, Bradley R (2012) PD patients had a significantly greater odds of deficiency in coenzyme Q10 status. Coenzyme Q10 deficiency in patients with Parkinson’s disease. J Neurol Sci 318:72–75

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Moshage H, Kok B, Huizenga JR (1995) Nitrite and nitrate determination in plasma: a critical evaluation. Clin Chem 41:892–896

    PubMed  CAS  Google Scholar 

  • Mulcahy P, Walsh S, Paucard A, Rea K, Dowd E (2011) Characterisation of a novel model of Parkinson’s disease by intra-striatal infusion of the pesticide rotenone. Neuroscience 181:234–242

    Article  PubMed  CAS  Google Scholar 

  • Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson’s disease. Annu Rev Neurosci 22:123–144

    Article  PubMed  CAS  Google Scholar 

  • Pankratz N, Foroud T (2007) Genetics of Parkinson disease. Genet Med 9:801–811

    Article  PubMed  Google Scholar 

  • Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT (2005) Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280:42026–42035

    Article  PubMed  CAS  Google Scholar 

  • Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson’s disease: a meta-analysis. Environ Res 86:122–127

    Article  PubMed  CAS  Google Scholar 

  • Ravenstijn PG, Merlini M, Hameetman M, Murray TK, Ward MA, Lewis H, Ball G, Mottart C, de Ville Goyet C, Lemarchand T, van Belle K, O’Neill MJ, Danhof M, de Lange EC (2008) The exploration of rotenone as a toxin for inducing Parkinson’s disease in rats, for application in BBB transport and PK-PD experiments. J Pharmacol Toxicol Methods 57:114–130

    Article  PubMed  CAS  Google Scholar 

  • Ren Y, Feng J (2007) Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism. J Neurochem 103:303–311

    PubMed  CAS  Google Scholar 

  • Rodrigo L, Hernández AF, López-Caballero JJ, Gil F, Pla A (2001) Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact 137:123–137

    Article  PubMed  CAS  Google Scholar 

  • Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383–388

    Article  PubMed  CAS  Google Scholar 

  • Santens P, Boon P, Van Roost D, Caemaert J (2003) The pathophysiology of motor symptoms in Parkinson’s disease. Acta Neurol Belg 103:129–134

    PubMed  CAS  Google Scholar 

  • Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172–188

    Article  PubMed  Google Scholar 

  • Schmidt WJ, Alam M (2006) Controversies on new animal models of Parkinson’s disease pro and con: the rotenone model of Parkinson’s disease (PD). J Neural Transm Suppl 70:273–376

    PubMed  CAS  Google Scholar 

  • Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904–1143

    Article  PubMed  CAS  Google Scholar 

  • Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, Rosati G (1996) Reduced intravenous glutathione in the treatment of early Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 20:1159–1170

    Article  PubMed  CAS  Google Scholar 

  • Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003a) Mechanism of toxicity in rotenone models of Parkinson’s disease. J Neurosci 23:10756–10764

    PubMed  CAS  Google Scholar 

  • Sherer TB, Kim JH, Betarbet R, Greenamyre JT (2003b) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179:9–16

    Article  PubMed  CAS  Google Scholar 

  • Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M, Parkinson Study Group (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59:1541–1550

    Article  PubMed  Google Scholar 

  • Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348–355

    Article  PubMed  CAS  Google Scholar 

  • Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, Suzuki Y, Okamoto K, Yamamoto Y (2004) Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson’s disease. J Neurol Sci 223:161–166

    Article  PubMed  CAS  Google Scholar 

  • Swarnkar S, Singh S, Sharma S, Mathur R, Patro IK, Nath C (2011) Rotenone induced neurotoxicity in rat brain areas: a histopathological study. Neurosci Lett 501:123–127

    Article  PubMed  CAS  Google Scholar 

  • Thiffault C, Langston JW, Di Monte DA (2000) Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res 885:283–288

    Google Scholar 

  • Townsend DM, Tew KD, Tapiero H (2003) The importance of glutathione in human disease. Biomed Pharmacother 57:145–155

    Google Scholar 

  • Uversky VN (2004) Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318:225–241

    Article  PubMed  CAS  Google Scholar 

  • Vanacore N, Nappo A, Gentile M, Brustolin A, Palange S, Liberati A, Di Rezzel S, Caldoral G, Gasparinil M, Benedetti F, Bonifatil V, Forastiere F, Quercia A, Mecol G (2002) Evaluation of risk of Parkinson’s disease in a cohort of licensed pesticide users. Neurol Sci 23(suppl. 2):S119–S120

    Google Scholar 

  • Wang W, Ballatori N (1998) Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev 50:335–356

    PubMed  CAS  Google Scholar 

  • Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M (1995) Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882–2891

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Wehr H, Bednarska-Makaruk M, Graban A, Lipczyńska-Łojkowska W, Rodo M, Bochyńska A, Ryglewicz D (2009) Paraoxonase activity and dementia. J NeurolSci 283:107–108

    CAS  Google Scholar 

  • Wei T, Chen C, Hou J, Xin W, Mori A (2000) Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta 1498:72–79

    Article  PubMed  CAS  Google Scholar 

  • Xiong N, Huang J, Zhang Z, Zhang Z, Xiong J, Liu X, Jia M, Wang F, Chen C, Cao X, Liang Z, Sun S, Lin Z, Wang T (2009) Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson’s disease. PLoS One 4:e7878

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Toxicology and Narcotics, National Research Centre, Tahrir St., Dokki, Cairo, Egypt

    Omar M. E. Abdel-Salam

  2. Department of Physiology, National Research Centre, Cairo, Egypt

    Yasser Ashry Khadrawy

  3. Department of Medical Biochemistry, National Research Centre, Cairo, Egypt

    Eman R. Youness, Nadia A. Mohammed & Jihan Seid Hussein

  4. Department of Pharmacology, National Research Centre, Cairo, Egypt

    Rehab Fawzy Abdel-Rahman

  5. Department of Pathology, National Research Centre, Cairo, Egypt

    Nermeen Shafee

Authors
  1. Omar M. E. Abdel-Salam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasser Ashry Khadrawy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eman R. Youness
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nadia A. Mohammed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rehab Fawzy Abdel-Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jihan Seid Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nermeen Shafee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Omar M. E. Abdel-Salam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdel-Salam, O.M.E., Khadrawy, Y.A., Youness, E.R. et al. Effect of a single intrastriatal rotenone injection on oxidative stress and neurodegeneration in the rat brain. Comp Clin Pathol 23, 1457–1467 (2014). https://doi.org/10.1007/s00580-013-1807-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-013-1807-4

Keywords

Search

Navigation